Position in NTRA
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$6,215,933
+$1,213,984 QoQ
Shares Held
22,899
-8.4% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#245
of 844 holders
Holding Since
Sep 2021
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026DAVENPORT & Co LLC holds $199,210,953 across 8 Diagnostics & Research names. NTRA ranks #3 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
678,343 | $129,210,774 | |
| 2 | A |
Agilent Technologies, Inc.
|
431,792 | $57,354,931 | |
| 3 | NTRA |
Natera, Inc.
This page
|
22,899 | $6,215,933 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
5,851 | $2,933,457 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
2,731 | $1,437,707 | |
| 6 | LH |
Labcorp Holdings Inc.
|
3,779 | $1,058,120 | |
| 7 | WAT |
Waters Corp /De/
|
1,498 | $561,809 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
2,268 | $438,222 |
All Filings in NTRA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,215,933 | 22,899 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $5,001,949 | 25,011 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $3,214,590 | 14,032 | Shares | Sole | 2026-01-12 | |
| 2021-12-31 | $336,110 | 3,599 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $326,073 | 2,926 | Shares | Sole | 2021-10-14 | |
| No filing history on record for this holder in this stock. | ||||||